{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":858,"total_is_capped":false,"direct_labels_cover":4,"predictions_cover":858,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"cf7ece18bb14","filters":{"venue":"BMC Cancer"}},"results":[{"id":"W2005852730","doi":"10.1186/1471-2407-12-91","title":"EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer","year":2012,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Queen's University","funders":"Queen's University; Canadian Institutes of Health Research; Terry Fox Foundation; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Slug; Epithelial–mesenchymal transition; Biology; Gene knockdown; Vimentin; Cancer research; Transdifferentiation; Gene expression profiling; Snail; Transcription factor; Metastasis; Transcriptome; Gene expression; Gene; Cell; Cancer; Genetics; Immunology; Immunohistochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03812918941999789,"gpt":0.3100399687607113,"spread":0.2719107793407134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002507096,0.0002012772,0.0004161307,0.0001300253,0.00005741792,0.00002046196,0.00005226244,0.00008998203,0.0007117069],"category_scores_gemma":[0.00004477795,0.0001755191,0.0000770789,0.0003482632,0.00003764797,0.0001511759,0.00001708078,0.0001593924,0.000007249409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004161763,"about_ca_system_score_gemma":0.0001855385,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006471393,"about_ca_topic_score_gemma":0.05994668,"domain_scores_codex":[0.998621,0.00004504762,0.0002854415,0.0003082161,0.0002469,0.000493338],"domain_scores_gemma":[0.9992633,0.00004934493,0.00006994155,0.0002054891,0.00006488117,0.0003470146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002141581,0.0001813051,0.7963895,0.0005856348,0.0001173721,0.000008766498,0.006237343,0.00003297131,0.168156,0.0005879448,0.01271974,0.01284187],"study_design_scores_gemma":[0.002505187,0.00003984004,0.7163269,0.0003844343,0.0001568235,0.000001982293,0.0001789731,0.000005082139,0.02787368,0.00001949066,0.2522569,0.0002507766],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9709265,0.02346585,0.000578044,0.001591454,0.0009001058,0.0006664909,0.0002799251,0.00003562023,0.001555975],"genre_scores_gemma":[0.9924362,0.00148009,0.0007995206,0.000701157,0.0004473254,0.0002550806,0.00001707449,0.00003309595,0.003830512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2395371,"threshold_uncertainty_score":0.9782853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1512863196","doi":"10.1186/1471-2407-3-26","title":"Follow-up of patients with curatively resected colorectal cancer: a practice guideline","year":2003,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; Hamilton Regional Laboratory Medicine Program; University of Ottawa; University of Toronto; McMaster University","funders":"Cancer Care Ontario","keywords":"Medicine; Randomized controlled trial; Colorectal cancer; Guideline; MEDLINE; Cochrane Library; Surgical oncology; Clinical trial; Internal medicine; Cancer; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.06286591613999173,"gpt":0.4003389568071809,"spread":0.3374730406671892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002306452,0.0007945739,0.003175944,0.0002489958,0.00007652232,0.00002056723,0.0002198647,0.0003992269,0.0016179],"category_scores_gemma":[0.00065234,0.0005283217,0.0006083394,0.001474424,0.0001757024,0.0001755562,0.00009137332,0.0005736424,0.00002386347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002023767,"about_ca_system_score_gemma":0.005048944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001482786,"about_ca_topic_score_gemma":0.0017703,"domain_scores_codex":[0.9957947,0.0004008682,0.001284552,0.0009000587,0.001073917,0.0005459069],"domain_scores_gemma":[0.9954281,0.0005526641,0.001501479,0.0005081833,0.001704009,0.0003054943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01413189,0.001613955,0.01231698,0.02084575,0.00542465,0.000132144,0.0002305185,0.000009120779,0.000001427839,0.00003935633,0.02732612,0.9179281],"study_design_scores_gemma":[0.00666833,0.001347409,0.0009773445,0.01296157,0.005959465,0.00002645029,0.00001817778,0.000003692902,0.0000118607,0.000001642695,0.9715285,0.0004955419],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001254082,0.9872761,0.00001893833,0.00005068399,0.0008867366,0.00405702,0.00124708,0.00006903242,0.005140305],"genre_scores_gemma":[0.0001248378,0.991694,0.001707884,0.0001657082,0.0002483523,0.002650687,0.0005540398,0.0001692773,0.002685195],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9442024,"threshold_uncertainty_score":0.9997168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165662097","doi":"10.1186/1471-2407-7-134","title":"Use of immunohistochemical markers can refine prognosis in triple negative breast cancer","year":2007,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":368,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; BC Cancer Agency; BioPhage Pharma (Canada); McGill University; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre","funders":"Jewish General Hospital; Michael Smith Health Research BC; Canadian Breast Cancer Research Alliance; Sanofi","keywords":"Immunohistochemistry; Breast cancer; Medicine; Surgical oncology; Triple-negative breast cancer; Basal (medicine); Triple negative; Phenotype; Oncology; Internal medicine; Pathology; Cancer; Biology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02280507854081824,"gpt":0.2928881368629361,"spread":0.2700830583221179,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001078097,0.0001962421,0.0002519284,0.00006586548,0.00003693059,0.000006715406,0.0001149157,0.0001175934,0.00009112414],"category_scores_gemma":[0.00004891527,0.0001821154,0.00009854893,0.0002305182,0.0001688397,0.000005148083,0.00008981249,0.00008474493,7.22997e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002886114,"about_ca_system_score_gemma":0.0002391728,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01953739,"about_ca_topic_score_gemma":0.03693761,"domain_scores_codex":[0.9988419,0.00003045061,0.0002945236,0.0003603667,0.0001453297,0.0003274493],"domain_scores_gemma":[0.9994223,0.00003685536,0.0001395366,0.0002154684,0.0001231027,0.00006269983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003532362,0.0002226256,0.8221049,0.00006974422,0.000279468,0.000005079288,0.0002659022,0.00006439201,0.1569353,0.0000189276,0.004154776,0.01234658],"study_design_scores_gemma":[0.00154367,0.00005555053,0.7989596,0.0001084987,0.00005412874,0.000008850669,0.000140314,0.000006174792,0.1972641,0.000005997669,0.001631102,0.0002219643],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958172,0.002324322,0.00002777405,0.0004097077,0.0002071718,0.0003306613,0.0005458163,0.00001062504,0.0003267571],"genre_scores_gemma":[0.9975554,0.0006854401,0.000707894,0.0001415084,0.0001686758,0.0002910145,0.00004432528,0.00002782034,0.0003778578],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04032884,"threshold_uncertainty_score":0.9869916,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2893838704","doi":"10.1186/s12885-018-4845-0","title":"N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer","year":2018,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":365,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Cancer Australia; Cancer Council South Australia; Government of South Australia","keywords":"Cadherin; Homing (biology); Cancer research; Metastasis; Epithelial–mesenchymal transition; Cancer cell; Cancer; Medicine; Surgical oncology; Cancer metastasis; Bone marrow; Immunology; Cell; Biology; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05465490844188629,"gpt":0.3580325680068088,"spread":0.3033776595649225,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004360749,0.0006371952,0.001385878,0.000273472,0.0000577403,0.00005310249,0.000424144,0.0006245841,0.0007226605],"category_scores_gemma":[0.00003481725,0.0005410156,0.0002290378,0.0005153646,0.00014482,0.00001516846,0.0002716415,0.0003878252,0.00001252226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003031407,"about_ca_system_score_gemma":0.001279878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001729391,"about_ca_topic_score_gemma":0.0103366,"domain_scores_codex":[0.9968365,0.0002715535,0.0008374631,0.001051576,0.0002663361,0.0007365932],"domain_scores_gemma":[0.999199,0.00002408842,0.0003201595,0.0002787987,0.00007988078,0.00009802427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001225967,0.000768836,0.06650219,0.02968081,0.001966105,0.0003775716,0.001721379,0.001926381,0.01326249,0.0002104322,0.007963125,0.8743947],"study_design_scores_gemma":[0.001089814,0.00008492042,0.001371049,0.007490607,0.0002234292,0.00003882598,0.00009530238,0.00005687934,0.002632631,0.00009412002,0.9856958,0.001126643],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03717763,0.9611988,0.00001985975,0.00006880434,0.0005328935,0.0007635518,0.0001041262,0.00001351519,0.0001208158],"genre_scores_gemma":[0.01383321,0.9813861,0.0001958905,0.0002247525,0.0004077177,0.002786895,0.00007976797,0.00008478435,0.001000943],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9777327,"threshold_uncertainty_score":0.9997041,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2920713811","doi":"10.1186/s12885-018-5232-6","title":"Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":363,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal General Hospital","funders":"NUTRIM School of Nutrition and Translational Research in Metabolism; KWF Kankerbestrijding; Rigshospitalet; Maastricht Universitair Medisch Centrum; Universiteit Maastricht; Sjællands Universitetshospital; Universitat de Barcelona; Danish Cancer Society Research Center; McGill University; Kræftens Bekæmpelse","keywords":"Prehabilitation; Medicine; Surgical oncology; Randomized controlled trial; Colorectal surgery; Colorectal cancer; Physical therapy; Multimodal therapy; Cancer; General surgery; Abdominal surgery; Surgery; Oncology; Physical medicine and rehabilitation; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01443316088607733,"gpt":0.2938125772934514,"spread":0.2793794164073741,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008073217,0.0002180081,0.0007714392,0.0001650513,0.0001038811,0.00003941357,0.00008593871,0.00011098,0.0001265102],"category_scores_gemma":[0.002676687,0.0001518453,0.0002652536,0.0001523246,0.0001469664,0.000260346,0.00003802204,0.000169549,0.000007299523],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006657048,"about_ca_system_score_gemma":0.0003179349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007156853,"about_ca_topic_score_gemma":0.001715049,"domain_scores_codex":[0.9979786,0.0002197468,0.0007107596,0.0005306444,0.0003430082,0.0002171993],"domain_scores_gemma":[0.9948868,0.003857218,0.0002594691,0.0001701152,0.0007496235,0.00007683839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9017082,0.0004730721,0.08497433,0.00008756241,0.0001976687,4.212261e-8,0.002428776,0.002708278,0.00575386,0.00009104764,0.0002848991,0.00129222],"study_design_scores_gemma":[0.6365942,0.000477986,0.3382187,0.0001561761,0.00007541852,3.968968e-7,0.000127007,0.02303146,0.0008744602,0.00007605766,0.0002139291,0.0001541311],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9684376,0.0001015642,0.0009836331,0.003929036,0.00279822,0.02339171,0.000219682,0.00002715205,0.0001114403],"genre_scores_gemma":[0.9620232,0.00001604269,0.002081483,0.0005820303,0.0002584178,0.03462458,0.0000843954,0.00002349734,0.0003063496],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.265114,"threshold_uncertainty_score":0.619207,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2922479144","doi":"10.1186/s12885-019-5353-6","title":"Cancer-associated fibroblasts induce epithelial–mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; The Society of Gynecologic Oncology of Canada; Centre hospitalier universitaire de Québec","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Urological Association; Ferring; Canadian Institutes of Health Research; Bladder Cancer Canada; Fonds de Recherche du Québec - Santé","keywords":"Epithelial–mesenchymal transition; Vimentin; Cancer-Associated Fibroblasts; Cancer research; Stromal cell; Bladder cancer; Cancer cell; Paracrine signalling; Exosome; Cancer; Medicine; Biology; Pathology; microRNA; Metastasis; Microvesicles; Internal medicine; Immunohistochemistry; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.03006305221598811,"gpt":0.3007506664874811,"spread":0.270687614271493,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002089436,0.0003738051,0.0008728182,0.0001119685,0.00007105134,0.00001884543,0.0001515722,0.0002140091,0.007707232],"category_scores_gemma":[0.00001701785,0.000338919,0.0003420334,0.0005567592,0.0001005939,0.0002147379,0.00003935839,0.0003565454,0.00005307296],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005173779,"about_ca_system_score_gemma":0.001089064,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02336498,"about_ca_topic_score_gemma":0.006566299,"domain_scores_codex":[0.9974381,0.0000819073,0.0006248448,0.0006116388,0.0006309001,0.0006125662],"domain_scores_gemma":[0.9986125,0.00009925525,0.0003867872,0.0003642481,0.0003583424,0.0001788656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001070314,0.0003490324,0.005912905,0.001003048,0.0006711868,0.00001114666,0.002153644,0.01395754,0.962517,0.00003211825,0.004408834,0.007913209],"study_design_scores_gemma":[0.005694079,0.0004210641,0.008893382,0.00188778,0.0009563168,0.000005838855,0.0004104485,0.001208323,0.9566478,0.00005939926,0.02321575,0.000599856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98829,0.005823701,0.000422181,0.0007115163,0.001410473,0.0009897531,0.001117206,0.00007562104,0.001159538],"genre_scores_gemma":[0.9879285,0.005901005,0.000593007,0.0008427395,0.0007339736,0.0002603338,0.00005373171,0.00008906205,0.003597717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01880692,"threshold_uncertainty_score":0.9999063,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131110909","doi":"10.1186/1471-2407-12-305","title":"Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial","year":2012,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation; BC Cancer Agency; Cancer Care Ontario","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"SABR volatility model; Medicine; Radiation therapy; Randomized controlled trial; Clinical endpoint; Quality of life (healthcare); Oncology; Internal medicine; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.2310737765766304,"gpt":0.4427291918940041,"spread":0.2116554153173737,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000365286,0.0003490197,0.001688709,0.0001935718,0.0001210752,0.00001304062,0.00005611736,0.000056092,0.0002335662],"category_scores_gemma":[0.0000815356,0.00022853,0.0007132319,0.0001955634,0.00008861749,0.0001060385,0.00001023554,0.00004044557,0.000001436337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003432869,"about_ca_system_score_gemma":0.0002884949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001899991,"about_ca_topic_score_gemma":0.00002251561,"domain_scores_codex":[0.9980921,0.000277982,0.0006806799,0.0003014372,0.0002388363,0.0004090193],"domain_scores_gemma":[0.9977103,0.001178063,0.0004173931,0.0002871124,0.0002213978,0.0001856811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9388292,0.0163459,0.02701752,0.0004208956,0.003853926,0.000003800916,0.006906969,0.000001538684,0.0004612915,0.00002713731,0.0001992758,0.005932544],"study_design_scores_gemma":[0.9473593,0.03582815,0.0004222962,0.00008713941,0.002531183,0.000004260436,0.0004328873,0.001675129,0.005011342,0.00001685962,0.006426089,0.0002053275],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.5348043,0.0004584417,0.00119228,0.00004666935,0.0001249097,0.4632311,0.0000848682,0.00003099369,0.00002639132],"genre_scores_gemma":[0.4238377,0.000008494872,0.003076945,0.00002926855,0.0002910568,0.5723029,0.00002376764,0.00003782842,0.0003919897],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.1109666,"threshold_uncertainty_score":0.9319185,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976022788","doi":"10.1186/1471-2407-14-177","title":"Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":309,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Breast cancer; Reproducibility; Medicine; Oncology; Internal medicine; Surgical oncology; Cancer; Pathology; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01071389454951906,"gpt":0.256795952167091,"spread":0.2460820576175719,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002471895,0.0003058571,0.0004379828,0.00008609051,0.0001564102,0.00003940867,0.0001765652,0.0001341815,0.00003451058],"category_scores_gemma":[0.00002601842,0.0002138318,0.0002428146,0.0004350981,0.0001740354,0.00001168331,0.0001096761,0.0000990782,7.71895e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001815574,"about_ca_system_score_gemma":0.0002678571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004811175,"about_ca_topic_score_gemma":0.0007840918,"domain_scores_codex":[0.9982861,0.0001920823,0.0003540522,0.0005200709,0.0003141011,0.000333585],"domain_scores_gemma":[0.9988027,0.00004819383,0.0003247308,0.0004337023,0.0003033971,0.00008726982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000577696,0.0001456914,0.9016674,0.0003149068,0.00160153,0.000001503009,0.00009575498,0.02321292,0.07168771,0.00007267125,0.0001709444,0.0004512838],"study_design_scores_gemma":[0.002449903,0.00007606115,0.7314496,0.0003606046,0.004687942,0.00006816203,0.0001377073,0.06239001,0.1976817,0.000007487661,0.0001138083,0.0005770256],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916072,0.0009002713,0.005527839,0.0002600671,0.0002008014,0.0005414239,0.0008947365,0.00002250652,0.00004515154],"genre_scores_gemma":[0.9986001,0.00001409792,0.0005277623,0.0001442803,0.0003856292,0.0001819891,0.00007579079,0.00003337821,0.00003697774],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1702178,"threshold_uncertainty_score":0.8719808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2809871933","doi":"10.1186/s12885-018-4610-4","title":"Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study","year":2018,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Incidence (geometry); Pancreatic cancer; Epidemiology; Adenocarcinoma; Population; Demography; Mortality rate; Disease; Surgical oncology; Malignancy; Cancer; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.105836799945135,"gpt":0.4150938013911253,"spread":0.3092570014459903,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001895768,0.000138451,0.0003728205,0.0004012908,0.00006454892,0.00002411259,0.0002173639,0.00007174467,0.000132163],"category_scores_gemma":[0.0002448571,0.00007706801,0.00002653759,0.001407635,0.0002583789,0.00004478054,0.00003994217,0.0003551849,0.000004963913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001752068,"about_ca_system_score_gemma":0.000334137,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02660633,"about_ca_topic_score_gemma":0.2273189,"domain_scores_codex":[0.9979038,0.0007646026,0.0003144845,0.0002704209,0.0004055521,0.0003411365],"domain_scores_gemma":[0.9986073,0.0008379273,0.00005785953,0.0003789614,0.0000623993,0.0000555328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002980709,0.0003278221,0.9884955,0.00004204866,0.00002044031,0.0001360901,0.01010816,0.00001749432,0.00001257183,0.00001637415,0.0001911295,0.0003342464],"study_design_scores_gemma":[0.003164408,0.0007046221,0.9801528,0.0001370927,0.00009848157,0.00001448071,0.008478519,0.006994304,0.000005983399,0.00008190362,0.00008819043,0.00007916448],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997334,0.0003860357,0.00002198009,0.0009719262,0.00002164197,0.0007963839,0.000008068965,0.000008639785,0.0004512951],"genre_scores_gemma":[0.9981303,0.00005521176,0.00006955492,0.001038787,0.00008873697,0.0004888967,0.00001267932,0.000009688677,0.000106115],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2007125,"threshold_uncertainty_score":0.9798756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112788544","doi":"10.1186/1471-2407-8-17","title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"Biological and Environmental Research; National Institutes of Health; National Cancer Institute; Office of Science; Michael Smith Health Research BC; U.S. Department of Energy","keywords":"Serous fluid; Loss of heterozygosity; Epigenetics; PTEN; Cancer research; Biology; DNA methylation; Germline mutation; Germline; Somatic cell; Mutation; Medicine; Pathology; Genetics; Gene; Gene expression; PI3K/AKT/mTOR pathway","retraction":null,"screen_n_in":null,"score":{"opus":0.02202225993340322,"gpt":0.253521751516172,"spread":0.2314994915827687,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003426417,0.0002181942,0.0003147779,0.00005661615,0.0001131917,0.00001853103,0.00005018677,0.00005726187,0.0003157348],"category_scores_gemma":[0.000007185733,0.000165933,0.00006244294,0.00009202402,0.0002145059,0.00003374247,0.00003004608,0.00008329396,0.000009569278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001631103,"about_ca_system_score_gemma":0.000379845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002801958,"about_ca_topic_score_gemma":0.001183109,"domain_scores_codex":[0.9988487,0.00002969694,0.0001860944,0.0003824972,0.0002475397,0.0003054307],"domain_scores_gemma":[0.9992912,0.00003162886,0.00006179948,0.0003361391,0.00007218842,0.0002070791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001702242,0.0000931337,0.9956172,0.0001269977,0.0001511788,0.0009897937,0.0004864781,0.00009888506,0.00006121646,0.00009455489,0.0002563233,0.001854054],"study_design_scores_gemma":[0.002908353,0.000364865,0.9888273,0.0001381283,0.0003089344,0.000651377,0.00005756578,0.00007645861,0.00298547,0.0000390979,0.003433042,0.0002094142],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830506,0.01305849,0.0006450044,0.0005948296,0.0000827204,0.0004470639,0.00004116925,0.0000350578,0.002045075],"genre_scores_gemma":[0.9946914,0.0009492443,0.002185847,0.0003657053,0.0001993304,0.0002830237,0.00001231953,0.00004128786,0.001271826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01210925,"threshold_uncertainty_score":0.6766552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052161680","doi":"10.1186/1471-2407-9-86","title":"The prevalence of BRCA1 mutations among young women with triple-negative breast cancer","year":2009,"lang":"en","type":"article","venue":"BMC Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":273,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Ohio State University","keywords":"Triple-negative breast cancer; Surgical oncology; Medicine; Breast cancer; Oncology; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.008442914987929932,"gpt":0.2701015140154827,"spread":0.2616585990275528,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001370578,0.0001468937,0.0001203663,0.00003004115,0.0001822852,0.00002602564,0.00025534,0.00007190961,0.0001483693],"category_scores_gemma":[0.00004726596,0.0001055961,0.00004478455,0.0002312832,0.0003048372,0.00001031988,0.00003065288,0.00008249684,0.000001406231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002468297,"about_ca_system_score_gemma":0.0008703248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004424294,"about_ca_topic_score_gemma":0.003414377,"domain_scores_codex":[0.9989541,0.00005558641,0.000206499,0.0003126727,0.0001970856,0.0002741231],"domain_scores_gemma":[0.9990865,0.0000303044,0.0001866118,0.0003623413,0.0002576606,0.00007658904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004205414,0.0003577247,0.7179415,0.000554429,0.001057777,0.000005345353,0.009099297,0.03391721,0.1357771,0.0006515482,0.02166183,0.0747709],"study_design_scores_gemma":[0.001072258,0.0002046101,0.9633148,0.00006837592,0.00007074998,0.00001503916,0.000660085,0.0001598524,0.03166563,0.0002192368,0.002298209,0.0002511612],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941301,0.002504673,0.000754031,0.000499737,0.0002253804,0.0004206789,0.0004157625,0.00001431588,0.001035339],"genre_scores_gemma":[0.9924343,0.001135476,0.0003999115,0.0001640113,0.0002319778,0.0005676571,0.00000769137,0.00001832032,0.005040705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2453733,"threshold_uncertainty_score":0.4306083,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4232184817","doi":"10.1186/s12885-019-5977-6","title":"Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Nova Scotia Cancer Centre; London Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Positive Living North; Western University","funders":"London Health Sciences Foundation; Ontario Institute for Cancer Research","keywords":"SABR volatility model; Medicine; Clinical endpoint; Radiation therapy; Randomized controlled trial; Oncology; Internal medicine; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.1551674464762097,"gpt":0.4150772401204597,"spread":0.25990979364425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003856267,0.0003559868,0.00169498,0.0001475006,0.00009768683,0.00002673869,0.00009761529,0.00005369411,0.00167213],"category_scores_gemma":[0.00006823069,0.0001918402,0.000794449,0.0002180031,0.0001005529,0.00006396671,0.0000104567,0.00004829776,0.000008222244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002921551,"about_ca_system_score_gemma":0.0004179245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003052795,"about_ca_topic_score_gemma":0.00004658482,"domain_scores_codex":[0.9980178,0.000289521,0.0006972144,0.0003949818,0.000288441,0.000311968],"domain_scores_gemma":[0.9957497,0.002954448,0.0004665835,0.0004399505,0.0002932414,0.00009614827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9761121,0.004191368,0.005772465,0.0003327911,0.004836943,0.000004971192,0.003012789,0.00001042691,0.0003142614,0.00001577742,0.000348363,0.005047728],"study_design_scores_gemma":[0.9485078,0.02300914,0.0002034368,0.00009385471,0.002484866,0.000002878824,0.0006418682,0.008740124,0.002176079,0.00001832635,0.01393645,0.000185137],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.4337029,0.0003996746,0.0007543698,0.0001065866,0.0001253082,0.5647411,0.00008148199,0.00002292283,0.00006576433],"genre_scores_gemma":[0.2896041,0.00001560223,0.0008542976,0.00004472545,0.0001919976,0.7037354,0.00002620974,0.0000471771,0.005480514],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.1440987,"threshold_uncertainty_score":0.9992405,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008870230","doi":"10.1186/1471-2407-13-537","title":"Wnt signaling in triple negative breast cancer is associated with metastasis","year":2013,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":251,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Clinical Research Institute; McGill University; St Mary's Hospital Centre","funders":"National Institute of General Medical Sciences; Winship Cancer Institute; National Cancer Institute; National Institutes of Health; Emory University; Georgia Research Alliance; Georgia Institute of Technology; U.S. Department of Defense","keywords":"Wnt signaling pathway; Cancer research; Breast cancer; Catenin; Medicine; Metastasis; KRAS; HMGA2; LRP5; Biology; Cancer; Oncology; Internal medicine; Signal transduction; Colorectal cancer; Gene; Genetics; microRNA","retraction":null,"screen_n_in":null,"score":{"opus":0.01646460076739436,"gpt":0.2544003135772877,"spread":0.2379357128098933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001519292,0.0002351898,0.0002528301,0.00006427926,0.00007312998,0.00004785568,0.000188925,0.0001364132,0.002214835],"category_scores_gemma":[0.00002680156,0.0001928053,0.00007684445,0.0003099253,0.00007740368,0.00001472846,0.00005962981,0.0001210731,0.00001744214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001592131,"about_ca_system_score_gemma":0.0004420186,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003106454,"about_ca_topic_score_gemma":0.003663585,"domain_scores_codex":[0.9986266,0.00005662339,0.0002510117,0.0004439548,0.0002263464,0.0003954854],"domain_scores_gemma":[0.999341,0.00002180154,0.0001485504,0.0001665205,0.0002346406,0.00008748206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007868913,0.0002479747,0.3834088,0.00008551393,0.00120082,0.000008756164,0.001381366,0.003814597,0.5344709,0.00001735284,0.06134606,0.01323095],"study_design_scores_gemma":[0.004504802,0.000148757,0.1804155,0.0004332197,0.0001422276,0.000008040144,0.0005091834,0.0002627325,0.8086686,0.0001705923,0.003648843,0.001087497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966125,0.001735887,0.000138003,0.0003927115,0.0001874002,0.0003973151,0.0001289562,0.00001953013,0.0003876237],"genre_scores_gemma":[0.9936775,0.0003208515,0.000414658,0.0008325536,0.000204023,0.0008487963,0.0000464877,0.0000419779,0.003613175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2741977,"threshold_uncertainty_score":0.9986973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976214427","doi":"10.1186/1471-2407-8-25","title":"Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":247,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; McMaster University; Population Health Research Institute","funders":"Brain Tumour Research; RWTH Aachen University; Bundesministerium für Bildung und Forschung","keywords":"Cancer research; Biology; Carcinogenesis; Estrogen receptor alpha; Gene expression profiling; Breast cancer; Molecular biology; Cancer; Estrogen receptor; Gene expression; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03338504700686015,"gpt":0.3144546420089779,"spread":0.2810695950021177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003123632,0.0002637561,0.0006403031,0.0003260386,0.000135204,0.00001903415,0.000361391,0.0001951014,0.00007372643],"category_scores_gemma":[0.0001100424,0.000219693,0.0002712173,0.0004256828,0.0001806569,0.00001300639,0.0002421936,0.0001528353,0.000003021537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001072119,"about_ca_system_score_gemma":0.0002028981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001144528,"about_ca_topic_score_gemma":0.003194292,"domain_scores_codex":[0.9976515,0.0002752005,0.0007091478,0.0005664988,0.0003643669,0.0004333003],"domain_scores_gemma":[0.9987646,0.00003169725,0.0002633588,0.0006481704,0.0001507525,0.0001414069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002289656,0.0002010291,0.07257627,0.001847841,0.0000840107,0.00002581204,0.0002400463,0.0005800397,0.9237535,0.000002608886,0.000405977,0.00005391195],"study_design_scores_gemma":[0.001081018,0.0001901739,0.004696496,0.002119816,0.00004247509,0.00001044852,0.0001976538,0.0008944125,0.990401,0.000007129872,0.00009248954,0.0002668293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911423,0.00359635,0.004263245,0.00002242644,0.00007736924,0.0007466466,0.00009365461,0.0000130245,0.00004501851],"genre_scores_gemma":[0.9975023,0.0002763427,0.0007122066,0.00002864091,0.0002417794,0.0006039905,0.0001016827,0.00003332808,0.0004997195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06787977,"threshold_uncertainty_score":0.895882,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026327850","doi":"10.1186/1471-2407-14-53","title":"Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials","year":2014,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Meta-analysis; MEDLINE; Adverse effect; Erythema; Skin cancer; Psychological intervention; Itching; Internal medicine; Dermatology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1085746444778882,"gpt":0.4413541601144289,"spread":0.3327795156365407,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.008352127,0.0004511607,0.06357718,0.0007259801,0.00002527019,0.00001435389,0.00005440352,0.0002175661,0.0002275034],"category_scores_gemma":[0.005786139,0.000222871,0.01123645,0.0005370525,0.00004714915,0.00005024302,0.000008447137,0.00007337439,0.000001295341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001659078,"about_ca_system_score_gemma":0.0003834876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001253933,"about_ca_topic_score_gemma":0.00004509707,"domain_scores_codex":[0.9879643,0.006543282,0.00465894,0.0003618291,0.0003632731,0.0001084315],"domain_scores_gemma":[0.9816325,0.009039087,0.00841473,0.0005616823,0.0002615399,0.00009041527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001349773,0.00005599297,5.435647e-7,0.4724531,0.5222327,2.918144e-7,0.00002213033,7.876221e-7,8.177425e-7,0.00003078111,0.00002466298,0.003828438],"study_design_scores_gemma":[0.06512131,0.0001737381,0.000001544656,0.0388364,0.8936409,0.000008106525,0.00000220316,0.00005136462,0.000002421148,0.000003939084,0.002034834,0.0001232527],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008618076,0.9711892,0.0001184459,0.00009008402,0.00005095681,0.02833546,0.0001645181,0.00001234431,0.00003034889],"genre_scores_gemma":[0.0000645101,0.9825227,0.0001870105,0.00003515436,0.00005453164,0.01540722,0.000157804,0.00002777614,0.001543271],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4336167,"threshold_uncertainty_score":0.9986658,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2935709215","doi":"10.1186/s12885-019-5380-3","title":"Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Pembrolizumab; Internal medicine; Thyroid cancer; Adverse effect; Cancer; Response Evaluation Criteria in Solid Tumors; Oncology; Gastroenterology; Thyroid; Papillary thyroid cancer; Surgery; Phases of clinical research; Clinical trial; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.005865330898942697,"gpt":0.2638558141154493,"spread":0.2579904832165066,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007340301,0.0002955449,0.0006623051,0.00007558633,0.0000739227,0.00001272029,0.0001094367,0.00008286942,0.0001698142],"category_scores_gemma":[0.00001516971,0.000166744,0.0001088658,0.0003774694,0.0001248196,0.0001796975,0.00009231448,0.0001855737,0.000003558603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004240628,"about_ca_system_score_gemma":0.000522007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002093147,"about_ca_topic_score_gemma":0.002289239,"domain_scores_codex":[0.9983611,0.00006877132,0.000272686,0.0005081508,0.0004363283,0.0003529913],"domain_scores_gemma":[0.9989543,0.00007320789,0.0002453689,0.0004791326,0.0001464414,0.0001015571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009340843,0.0004909948,0.9819492,0.0002661301,0.0001946137,0.00001258836,0.0001713108,0.0003471092,0.002947077,0.00003017432,0.00006561802,0.004184322],"study_design_scores_gemma":[0.01386274,0.001000077,0.9712725,0.001274208,0.0002056519,0.000005626293,0.00004753283,0.00004502908,0.01130907,0.000002815869,0.0007520731,0.0002227127],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991745,0.005203856,0.000009231219,0.0003069796,0.0002496673,0.001813847,0.0002806833,0.0000180033,0.0003727073],"genre_scores_gemma":[0.9941097,0.004990183,0.000064883,0.000237477,0.00005725089,0.0001388324,0.0000204095,0.0000421892,0.0003390414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01067676,"threshold_uncertainty_score":0.6799623,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2991007821","doi":"10.1186/s12885-019-6284-y","title":"MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators","year":2019,"lang":"en","type":"review","venue":"BMC Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":217,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Surgical oncology; Medicine; microRNA; Pancreatic cancer; Oncology; Cancer; Bioinformatics; Internal medicine; Cancer research; Biology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.0351221882416257,"gpt":0.3239078614716095,"spread":0.2887856732299838,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001122829,0.0003929805,0.0007504275,0.0001180773,0.0000293803,0.00003163473,0.0001886164,0.0003851985,0.00006789342],"category_scores_gemma":[0.00002379112,0.0003435999,0.0002128999,0.0001820809,0.00007383378,0.000002735486,0.0001057718,0.0001142956,0.00001217385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001554059,"about_ca_system_score_gemma":0.0008100261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000238565,"about_ca_topic_score_gemma":0.0003462519,"domain_scores_codex":[0.9984332,0.0001390963,0.00038257,0.0006419969,0.00009858445,0.0003044954],"domain_scores_gemma":[0.9991771,0.00003071254,0.0002572542,0.0004289442,0.00003931739,0.00006665415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005683375,0.00006292122,0.02010297,0.02727873,0.0008196295,0.000002592668,0.00002072072,0.00003334768,0.003984767,0.00001306604,0.001180542,0.9464439],"study_design_scores_gemma":[0.0004485963,0.00003183811,0.00465124,0.007068012,0.001000742,0.00001197857,0.000004859706,0.00003047545,0.0002829875,0.000007871735,0.9859195,0.0005419391],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01292483,0.9851625,0.0000184954,0.0000081646,0.0002896312,0.001363053,0.000179768,0.00001061768,0.00004292026],"genre_scores_gemma":[0.001889092,0.9963732,0.00007798754,0.00003241044,0.0001966669,0.0006260248,0.0002268351,0.00008489707,0.0004928416],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9847389,"threshold_uncertainty_score":0.9999016,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047846334","doi":"10.1186/1471-2407-9-186","title":"Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions","year":2009,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":214,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Consejo Nacional de Ciencia y Tecnología; Terry Fox Foundation","keywords":"NKG2D; Cervical cancer; Cancer research; Squamous intraepithelial lesion; Medicine; Flow cytometry; Cytolysis; Immunology; Cancer; Context (archaeology); Cervical intraepithelial neoplasia; Cytotoxic T cell; Biology; Internal medicine; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.01904912170943493,"gpt":0.2772067000528182,"spread":0.2581575783433833,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008411556,0.0001688058,0.0002206734,0.0001033865,0.0001432757,0.00002210239,0.00004651421,0.0002264974,0.0004735528],"category_scores_gemma":[0.00002250572,0.0001439664,0.00002968899,0.00007606961,0.00008624448,0.0001490589,0.00003839758,0.0003271158,0.00002062599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008380297,"about_ca_system_score_gemma":0.00005320147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004044468,"about_ca_topic_score_gemma":0.0003994059,"domain_scores_codex":[0.9990926,0.0001238837,0.0001597195,0.0003620658,0.00003151077,0.0002302444],"domain_scores_gemma":[0.9996248,0.00009690052,0.00007882014,0.0001404931,0.00002410104,0.00003492159],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009151866,0.0001273095,0.001373358,0.00003023005,0.00001045156,8.182669e-7,0.0002755455,0.00001277611,0.9729597,0.00001979213,0.00446138,0.01981347],"study_design_scores_gemma":[0.00157676,0.0002372561,0.1642497,0.0003019787,0.00001786574,0.000009258797,0.0000905571,0.00003332811,0.8250009,0.00002955821,0.00826213,0.0001907415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945614,0.00300105,0.00001922072,0.0004309494,0.001069065,0.0002667027,0.00001413506,0.00003176537,0.0006056807],"genre_scores_gemma":[0.9914754,0.002340279,0.00002008287,0.0003677989,0.00005173217,0.00005847488,0.000007665406,0.00001082502,0.005667764],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1628763,"threshold_uncertainty_score":0.5870781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048623699","doi":"10.1186/1471-2407-9-433","title":"HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy","year":2009,"lang":"en","type":"article","venue":"BMC Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Eli Lilly Canada; Michael Smith Health Research BC; Sanofi; BC Cancer Agency; Eli Lilly and Company","keywords":"Trastuzumab; Medicine; Mucinous carcinoma; Oncology; Carboplatin; Mucinous Tumor; Surgical oncology; Ovarian cancer; Chemotherapy; Internal medicine; Targeted therapy; Paclitaxel; Immunohistochemistry; Cancer; Pathology; Adenocarcinoma; Breast cancer; Cisplatin","retraction":null,"screen_n_in":null,"score":{"opus":0.06060265793451496,"gpt":0.3509393049700187,"spread":0.2903366470355037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001601632,0.0001424148,0.0002854505,0.0001284561,0.00003760163,0.00001653252,0.00006409732,0.00008367351,0.0001567622],"category_scores_gemma":[0.00001684196,0.0001076873,0.00002167818,0.0002513046,0.00009861789,0.0000528193,0.00001614625,0.0001742328,2.379319e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002027611,"about_ca_system_score_gemma":0.0004768853,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01090535,"about_ca_topic_score_gemma":0.002292585,"domain_scores_codex":[0.998727,0.00006363048,0.0002169941,0.0003515012,0.0003816189,0.0002593024],"domain_scores_gemma":[0.9993366,0.00004202752,0.00007602908,0.0003020607,0.00009809554,0.0001451812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004586752,0.0003883995,0.8046858,0.0003978701,0.00005548092,0.00002396828,0.009896623,0.00003942483,0.1303326,0.00007955317,0.003609058,0.04590444],"study_design_scores_gemma":[0.00392262,0.0009471728,0.9551312,0.0003799433,0.00001549998,0.00001946338,0.0002908294,0.0004408956,0.03553255,0.00005694307,0.003130832,0.0001320158],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917222,0.004237492,0.0000407888,0.002705371,0.00001770325,0.0008696469,0.00006868532,0.00001616577,0.0003219155],"genre_scores_gemma":[0.9975076,0.0012072,0.0004459954,0.0003805434,0.00008352822,0.00009483886,0.00001792969,0.00001979315,0.0002425412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1504454,"threshold_uncertainty_score":0.9956811,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138164563","doi":"10.1186/1471-2407-11-293","title":"Differences in integrin expression and signaling within human breast cancer cells","year":2011,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research; Saskatchewan Health Research Foundation","keywords":"Integrin; Vitronectin; Focal adhesion; Cell biology; Cancer research; Fibronectin; Cell adhesion; Cancer cell; Biology; Signal transduction; Extracellular matrix; Cell; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.08370830005526561,"gpt":0.3350740006811105,"spread":0.2513657006258448,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000152072,0.0001337391,0.0002390771,0.0001452422,0.00005058375,0.00001804482,0.00009521915,0.00008231989,0.003031629],"category_scores_gemma":[0.00001243943,0.00009817413,0.00003440458,0.0001513341,0.00009944918,0.00005983843,0.00009604116,0.0002879572,0.000009742628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000110638,"about_ca_system_score_gemma":0.0001570692,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007418266,"about_ca_topic_score_gemma":0.003407241,"domain_scores_codex":[0.9988861,0.00006170764,0.0002201215,0.0003101818,0.0002766851,0.0002452111],"domain_scores_gemma":[0.9995171,0.00003447005,0.00006026231,0.0001720983,0.00006203529,0.0001539973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002046756,0.00006217822,0.360374,0.0001180746,0.000006884657,0.00002053959,0.001363309,0.000002388719,0.6365984,0.00002032017,0.0002038178,0.001025352],"study_design_scores_gemma":[0.001113338,0.00007439343,0.4825924,0.0009580624,0.00001797705,0.0000101717,0.0005416463,0.0002162945,0.5141864,0.00007169829,0.00006685761,0.0001506812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997372,0.0008410539,0.00004872637,0.00005617359,0.00009263642,0.0002640853,0.00001285598,0.00002304254,0.00128944],"genre_scores_gemma":[0.9969872,0.0002088736,0.0005700803,0.00009510622,0.0001051583,0.0001138321,0.000001832434,0.00002158279,0.001896346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.122412,"threshold_uncertainty_score":0.9991914,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1782227983","doi":"10.1186/1471-2407-6-118","title":"Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study","year":2006,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Surgical oncology; Multiple myeloma; Radiation therapy; Internal medicine; Chemotherapy; Multivariate analysis; Retrospective cohort study; Oncology; Plasmacytoma; Proportional hazards model; Surgery; Radiology","retraction":null,"screen_n_in":null,"score":{"opus":0.0316934650049213,"gpt":0.3289340679808081,"spread":0.2972406029758868,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008432021,0.0001629731,0.0003047547,0.00006479064,0.00005942493,0.000008285905,0.0001051308,0.00004790877,0.0002199744],"category_scores_gemma":[0.00007009911,0.00009714647,0.0001031761,0.0003092879,0.00006692733,0.0000363064,0.00007899098,0.0001705599,0.000004258598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002721323,"about_ca_system_score_gemma":0.0003148609,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02784506,"about_ca_topic_score_gemma":0.09098697,"domain_scores_codex":[0.9985431,0.0000967797,0.0002888454,0.0002536407,0.0004001815,0.0004174596],"domain_scores_gemma":[0.9993429,0.0001351343,0.00008178339,0.000282874,0.00007489257,0.00008246974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006312688,0.0007800105,0.995591,0.0001051213,0.00008978132,0.00005092421,0.0003143751,0.0006556429,0.0001354801,0.000002492789,0.000909276,0.0007346382],"study_design_scores_gemma":[0.005430136,0.0001325794,0.9918314,0.0003783937,0.00009499447,0.000002096607,0.0002659148,0.000868484,0.0006372114,0.000009526958,0.0002644648,0.0000848165],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952622,0.002078651,0.000002071725,0.0001181997,0.000211192,0.002011342,0.00006897522,0.00001968343,0.0002277015],"genre_scores_gemma":[0.9982022,0.00004438287,0.00006554808,0.00003642548,0.0002229866,0.0005312819,0.00001416453,0.00002379673,0.000859205],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06314191,"threshold_uncertainty_score":0.9786286,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146873467","doi":"10.1186/1471-2407-8-230","title":"Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"National Cancer Institute; National Human Genome Research Institute; National Institutes of Health","keywords":"TMPRSS2; Prostate cancer; Fusion gene; Erg; Oncology; Prostate; Population; Medicine; Internal medicine; Cancer research; Cancer; Biology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.06964547080744926,"gpt":0.3871040679308264,"spread":0.3174585971233772,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002385333,0.0001310055,0.0005216799,0.00007479099,0.00006196433,0.000004713689,0.00004252741,0.00008300245,0.00004437171],"category_scores_gemma":[0.000159683,0.0000870755,0.00005228835,0.0001711529,0.00004688598,0.00004309064,0.00002374424,0.0001305594,6.681926e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002518058,"about_ca_system_score_gemma":0.0005409435,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01147299,"about_ca_topic_score_gemma":0.004382244,"domain_scores_codex":[0.9983752,0.0000897154,0.0005755629,0.0002881296,0.0005053556,0.0001659865],"domain_scores_gemma":[0.9985858,0.0002777344,0.0004813485,0.0002248856,0.0003381513,0.00009212201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005655814,0.0006448135,0.990244,0.00006728535,0.0002633554,0.00001321557,0.0009613477,0.0000472817,0.0004013058,1.704338e-7,0.0001406392,0.001560742],"study_design_scores_gemma":[0.01427537,0.0008143758,0.9832552,0.0002022517,0.0002527223,3.624618e-7,0.0001204478,0.0003465695,0.000571181,0.000001492513,0.00007187765,0.00008816436],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973258,0.0003784717,0.000006511699,0.0003658682,0.0001295672,0.0009448223,0.0008164588,0.00001576583,0.00001677998],"genre_scores_gemma":[0.9967214,0.001138308,0.0003028444,0.00005053982,0.00009693878,0.0001111404,0.000234592,0.00001874785,0.001325443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008619552,"threshold_uncertainty_score":0.9951097,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003432147","doi":"10.1186/1471-2407-14-609","title":"MMP-9 expression varies according to molecular subtypes of breast cancer","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":190,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut National de la Recherche Scientifique; Université du Québec à Montréal; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Breast cancer; Surgical oncology; Metastasis; Cancer; CA15-3; Medicine; Tissue microarray; Oncology; Cancer research; CA 15-3; Breast carcinoma; Clinical significance; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.008153173330194049,"gpt":0.2590221345416002,"spread":0.2508689612114061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000916392,0.0001176723,0.0001381609,0.00003081244,0.00004281729,0.00001225001,0.0001444457,0.00009157285,0.00008318119],"category_scores_gemma":[0.00003185104,0.0001046881,0.00006702973,0.00006956697,0.00002354888,0.000004664409,0.0001166232,0.00004069381,0.000005111319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000156729,"about_ca_system_score_gemma":0.00009690678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002613436,"about_ca_topic_score_gemma":0.0000965451,"domain_scores_codex":[0.9992586,0.00003876664,0.0001349067,0.0002621127,0.0001210474,0.0001846103],"domain_scores_gemma":[0.9994966,0.000005169791,0.00006676972,0.0002631795,0.000088264,0.00008000102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001268587,0.00001606168,0.004175299,0.00003545539,0.00001348376,2.720362e-7,0.0000199976,0.0002554305,0.9918992,0.0002138394,0.001455211,0.001788916],"study_design_scores_gemma":[0.0002402252,0.00007152697,0.001223962,0.00009707817,0.00001439625,0.000001881381,0.00002664043,0.00004197883,0.989999,0.0001333443,0.008003115,0.000146884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9749036,0.001229735,0.02259333,0.0001509335,0.0003214425,0.0001791054,0.00007008156,0.00001305551,0.0005386725],"genre_scores_gemma":[0.9974791,0.00007448892,0.001173822,0.0004797551,0.0004191042,0.0001197188,0.00001055793,0.00002178367,0.0002216973],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02257543,"threshold_uncertainty_score":0.4269057,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054146518","doi":"10.1186/1471-2407-11-210","title":"Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients","year":2011,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"Cancer Research Society","keywords":"Surgical oncology; Medicine; Ascites; Ovarian cancer; Oncology; Internal medicine; Cancer; Gynecology; General surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.06031674189053925,"gpt":0.2935587730519888,"spread":0.2332420311614495,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009172373,0.0001855312,0.000384481,0.0001108229,0.00002839633,0.000008113959,0.00006709692,0.00007640451,0.0008133964],"category_scores_gemma":[0.00005616027,0.0001534732,0.00005767321,0.0002508364,0.0001011356,0.00008687872,0.00003477594,0.0000968062,0.000005537318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002011033,"about_ca_system_score_gemma":0.0003637809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006137923,"about_ca_topic_score_gemma":0.003142287,"domain_scores_codex":[0.9987723,0.00003349837,0.0003240825,0.0003745846,0.0002216245,0.0002739301],"domain_scores_gemma":[0.9993047,0.00007739082,0.0001431739,0.000217497,0.0001296508,0.0001275539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001741222,0.0005511201,0.9870569,0.0002368216,0.00008621711,0.000009048761,0.000915809,0.000005183177,0.0004020924,0.0001824007,0.0002907452,0.01008954],"study_design_scores_gemma":[0.003150571,0.0003092522,0.9856668,0.000572114,0.000163243,0.0000011274,0.00004968346,0.00002462087,0.008845497,0.000135785,0.0009282457,0.0001531226],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993929,0.002808001,0.00003656296,0.0002004791,0.0002835391,0.001018937,0.0003425427,0.00001835392,0.001362541],"genre_scores_gemma":[0.9967756,0.0006764305,0.001185325,0.0001856782,0.00009557053,0.0008023583,0.000007864379,0.0000272619,0.0002438685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009936414,"threshold_uncertainty_score":0.9278745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3014481596","doi":"10.1186/s12885-020-06766-9","title":"Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review","year":2020,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia Hospital; St. Paul's Hospital; Research Canada; BC Cancer Agency; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Epidemiology; Colorectal cancer; Surgical oncology; Epidemiology of cancer; MEDLINE; Cancer; Population; Young adult; Demography; Gerontology; Oncology; Environmental health; Internal medicine; Breast cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1019665856210992,"gpt":0.4094627404229639,"spread":0.3074961548018647,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001562997,0.000491221,0.006226603,0.000362843,0.00004306195,0.000005418185,0.0003692155,0.0002809996,0.0002666926],"category_scores_gemma":[0.001353663,0.0002902308,0.001193906,0.002160366,0.0001090128,0.00003042698,0.00006545531,0.0008102587,0.00001674295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007356765,"about_ca_system_score_gemma":0.001062285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002503531,"about_ca_topic_score_gemma":0.008405908,"domain_scores_codex":[0.9953156,0.001565596,0.001807342,0.0005810109,0.0003473608,0.0003831343],"domain_scores_gemma":[0.9966725,0.001302255,0.00128329,0.0005337763,0.00009004758,0.0001181722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002357466,0.00002586015,0.0006593664,0.8148929,0.0002459543,0.00001797319,0.0001017268,0.000001220104,5.7624e-8,0.000009287702,0.004790036,0.1790199],"study_design_scores_gemma":[0.0003545071,0.0005286569,0.0006412714,0.7812949,0.007754657,0.0004663762,0.00002695147,0.0000411231,4.65728e-7,0.000005338789,0.2085947,0.0002909781],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001496712,0.9953595,0.0000193308,0.0005403727,0.0005055784,0.002764537,0.000188638,0.00005034468,0.0005566954],"genre_scores_gemma":[0.000322364,0.9912404,0.00005656082,0.0008426256,0.0003727008,0.006566687,0.00008797818,0.00005335491,0.000457361],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2038047,"threshold_uncertainty_score":0.999955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034277347","doi":"10.1186/1471-2407-10-4","title":"Residual γH2AX foci as an indication of lethal DNA lesions","year":2010,"lang":"en","type":"article","venue":"BMC Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":179,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Atomic Energy (Canada); BC Cancer Agency","funders":"","keywords":"DNA damage; Clonogenic assay; DNA repair; Molecular biology; RAD51; Biology; Cancer research; DNA; Cell; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01529833185979639,"gpt":0.3057114466361602,"spread":0.2904131147763638,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001199737,0.00007261639,0.00007213005,0.00002599802,0.00003653386,0.000006388786,0.0001500111,0.0001530064,0.0001535824],"category_scores_gemma":[0.00007152878,0.00007122557,0.00004153186,0.00004403258,0.00005305798,0.000003472538,0.0000548317,0.00007707457,0.00001061847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007635131,"about_ca_system_score_gemma":0.000234801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001711543,"about_ca_topic_score_gemma":0.001622867,"domain_scores_codex":[0.9994131,0.00002984394,0.0001149869,0.0002130668,0.0001104997,0.0001184506],"domain_scores_gemma":[0.9994513,0.00000603297,0.00007765839,0.0003458095,0.00005726796,0.0000618772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003539991,0.00003527114,0.001565002,0.00000776998,0.000009449783,4.591791e-7,0.00004501566,0.000004724118,0.9940767,0.001036293,0.0008179759,0.00236598],"study_design_scores_gemma":[0.0002416005,0.000138255,0.009359729,0.000005304134,0.0000131785,0.00000709309,0.00004258544,0.000009298496,0.9822586,0.0005922449,0.007238377,0.00009371014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973943,0.00009655156,0.0002083261,0.00006589342,0.0002512072,0.0001078778,0.00002881931,0.00001249167,0.00183458],"genre_scores_gemma":[0.996163,0.00002450566,0.002215076,0.00009086421,0.0003670463,0.0000412923,0.00006599753,0.00001588179,0.001016378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01181804,"threshold_uncertainty_score":0.2904494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1490453899","doi":"10.1186/1471-2407-6-114","title":"SNP-SNP interactions in breast cancer susceptibility","year":2006,"lang":"en","type":"article","venue":"BMC Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"Medical Research and Materiel Command; National Institutes of Health; National Cancer Institute; Cancer Care Ontario; U.S. Department of Defense","keywords":"Single-nucleotide polymorphism; Breast cancer; SNP; Odds ratio; Oncology; Biology; Medicine; Genetics; Cancer; Bioinformatics; Internal medicine; Genotype; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02375529941519854,"gpt":0.3324274074278973,"spread":0.3086721080126987,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000980968,0.000149771,0.0001270054,0.0000610405,0.00006054328,0.00002382492,0.0001547491,0.00008108343,0.0009429555],"category_scores_gemma":[0.00001224621,0.0001553129,0.000083553,0.000203751,0.0000871343,0.000008272893,0.0000695804,0.0001178004,0.00001797548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004294888,"about_ca_system_score_gemma":0.000524469,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.008812746,"about_ca_topic_score_gemma":0.1519601,"domain_scores_codex":[0.9988976,0.00004821973,0.0002436945,0.000433989,0.0001136831,0.0002628557],"domain_scores_gemma":[0.9993913,0.0000124103,0.00007599461,0.0003643235,0.0001133458,0.00004262101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001574997,0.0001513645,0.6819541,0.00003881299,0.00003303488,0.000001494806,0.00005747339,0.01067466,0.2468978,0.00007739287,0.05475576,0.005200577],"study_design_scores_gemma":[0.001011329,0.00002211626,0.804973,0.00005541532,0.00002998279,0.00001908793,0.0001182587,0.0003765489,0.05934845,0.0002260464,0.1334035,0.0004162316],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913362,0.002093679,0.0008351569,0.001078451,0.0009347801,0.0002405321,0.0003511176,0.00002320273,0.00310686],"genre_scores_gemma":[0.9940735,0.0002159606,0.0005807396,0.0003010282,0.001033152,0.000380495,0.0000742131,0.0000278353,0.00331315],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1875494,"threshold_uncertainty_score":0.9999703,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3127368180","doi":"10.1186/s12885-021-08241-5","title":"Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis","year":2021,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Cochrane Library; Cardiothoracic surgery; Surgical oncology; Lung cancer; Surgery; Subgroup analysis; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1349345710667778,"gpt":0.4011939349264694,"spread":0.2662593638596916,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001012427,0.001923177,0.01368158,0.001849494,0.0002236337,0.0002142376,0.0003634827,0.0007043821,0.001844621],"category_scores_gemma":[0.0001639812,0.001251727,0.008592988,0.005477228,0.00009442102,0.0002092263,0.0001672701,0.0007012885,0.000007659693],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006742002,"about_ca_system_score_gemma":0.009707995,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00395942,"about_ca_topic_score_gemma":0.02827079,"domain_scores_codex":[0.9915072,0.0007774457,0.002464701,0.002537674,0.001248397,0.00146463],"domain_scores_gemma":[0.9902602,0.004321939,0.002170836,0.001798439,0.0008741443,0.000574421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.004636822,0.002524095,0.2137031,0.1059201,0.2911387,0.0003905849,0.0000798025,0.000258212,1.852203e-7,4.195894e-7,0.01237619,0.3689719],"study_design_scores_gemma":[0.003511933,0.0002128844,0.02209305,0.02293401,0.8415418,0.00000970484,0.00003182124,0.0001325275,0.00003431265,9.223221e-8,0.1077197,0.001778178],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002062885,0.9871144,0.0004246473,0.0001163573,0.001135704,0.007217824,0.001735325,0.0001208869,0.00007197433],"genre_scores_gemma":[0.003117266,0.9553955,0.001468968,0.0001777454,0.0004420763,0.03329572,0.003843787,0.000427402,0.001831545],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5504031,"threshold_uncertainty_score":0.9993512,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2547748385","doi":"10.1186/s12885-016-2891-z","title":"Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta–analysis","year":2016,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria","funders":"National Institutes of Health","keywords":"Medicine; Confounding; Prostate cancer; Relative risk; Meta-analysis; Prostate; Cohort study; Demography; Oncology; Environmental health; Cancer; Internal medicine; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.3321519789104985,"gpt":0.5064631985710883,"spread":0.1743112196605898,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007071591,0.0006384343,0.009308826,0.0003735345,0.0001420978,0.0000348821,0.0001207466,0.0002959574,0.003381919],"category_scores_gemma":[0.0002879281,0.0003550556,0.002526011,0.0004151164,0.00007999425,0.00006701439,0.00004137343,0.0002939258,0.0001339339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004983647,"about_ca_system_score_gemma":0.0009931959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001995944,"about_ca_topic_score_gemma":0.0004302811,"domain_scores_codex":[0.9966969,0.0004509936,0.001277136,0.0007931209,0.0003383332,0.0004435373],"domain_scores_gemma":[0.9962884,0.0007212582,0.001653433,0.0006972808,0.0002846905,0.0003549136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00001944367,0.00001347239,0.0001152058,0.9100199,0.05946349,0.000001183908,0.00004389954,2.337686e-8,5.095493e-8,0.000005135126,0.0009100094,0.02940815],"study_design_scores_gemma":[0.0004568979,0.00003219964,0.00004943434,0.2090244,0.5957557,0.00001128968,9.336195e-7,0.000006035101,1.518776e-7,0.000001450082,0.1944062,0.0002553296],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001986207,0.9715379,0.0002048047,0.000384296,0.0001178913,0.01938693,0.008283485,0.00007334961,0.00000931694],"genre_scores_gemma":[0.000004370176,0.9638505,0.0001249519,0.002019238,0.0001075063,0.02849826,0.00005796874,0.00008055706,0.005256675],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7009956,"threshold_uncertainty_score":0.9998901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2021844025","doi":"10.1186/1471-2407-10-103","title":"Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance","year":2010,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":165,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; University of Pennsylvania","keywords":"Lovastatin; Ovarian cancer; Doxorubicin; Statin; Medicine; Apoptosis; Cancer research; Pharmacology; HMG-CoA reductase; Cisplatin; Cancer cell; Ovarian carcinoma; Cancer; Chemotherapy; Oncology; Internal medicine; Reductase; Biology; Cholesterol; Biochemistry; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.008178651809952028,"gpt":0.245967567772755,"spread":0.237788915962803,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000971972,0.0001932618,0.0002424658,0.00004100507,0.00006328866,0.00002291478,0.0001444569,0.0001402482,0.0001201265],"category_scores_gemma":[0.00001161064,0.0001556251,0.00006230902,0.0001037114,0.0002107554,0.000008776025,0.00005058482,0.0001443216,9.754648e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009225158,"about_ca_system_score_gemma":0.0003040539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001630794,"about_ca_topic_score_gemma":0.004313354,"domain_scores_codex":[0.9989686,0.00003301529,0.000195223,0.000384935,0.0001622614,0.000255963],"domain_scores_gemma":[0.9993235,0.0000150971,0.000154439,0.0003021362,0.0001172457,0.00008750696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003119119,0.00003075666,0.001697947,0.00006314994,0.00008662653,4.166066e-8,0.0001027714,0.0001857845,0.9814309,0.00009556224,0.002074495,0.01391999],"study_design_scores_gemma":[0.001100239,0.000103257,0.00863192,0.00003841749,0.0001087927,0.00000423458,0.00009100394,0.00002513422,0.8428826,0.00003212076,0.1467292,0.0002531732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872902,0.006953391,0.0008429215,0.0001330447,0.004244406,0.0002042179,0.0001144375,0.000010423,0.000206952],"genre_scores_gemma":[0.9871783,0.005120518,0.001424224,0.0002487525,0.004759036,0.0001051553,0.00001101983,0.00003624709,0.001116804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1446547,"threshold_uncertainty_score":0.6346206,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1498149942","doi":"10.1186/s12885-015-1529-x","title":"TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)","year":2015,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; Mount Sinai Hospital","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"Medicine; Perioperative; Epirubicin; Chemoradiotherapy; Chemotherapy; Surgery; Cancer; Randomized controlled trial; Surgical oncology; Clinical endpoint; Chemotherapy regimen; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06666730756198039,"gpt":0.3813577451423654,"spread":0.314690437580385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007188062,0.000445402,0.001174972,0.0002366556,0.0001400954,0.00008902093,0.000466854,0.0001550121,0.0008378375],"category_scores_gemma":[0.0004437872,0.0003203705,0.0004940451,0.0005832864,0.0002482805,0.0004825574,0.00007733528,0.0002543518,0.000001590805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001404132,"about_ca_system_score_gemma":0.002163542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001564436,"about_ca_topic_score_gemma":0.001573764,"domain_scores_codex":[0.9969786,0.0001940571,0.0009631276,0.0006236546,0.0008209712,0.0004195521],"domain_scores_gemma":[0.9973705,0.0001967005,0.0006990238,0.0005674992,0.0009773447,0.0001889357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9736115,0.0008376342,0.0008368224,0.00008983022,0.0009829223,0.000001329412,0.01065967,0.0008657115,0.002366458,0.0001698016,0.002175176,0.007403197],"study_design_scores_gemma":[0.9574728,0.006088682,0.0006094196,0.0001588018,0.0004437264,0.000002097967,0.002746232,0.008056275,0.01482446,0.000009445333,0.009276529,0.0003115236],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787055,0.0005587226,0.001437151,0.001824197,0.003895192,0.01055361,0.0002056669,0.00004752913,0.002772438],"genre_scores_gemma":[0.9794592,0.001005009,0.00128968,0.0006437678,0.002812708,0.004312673,0.0001359928,0.00009298605,0.01024799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01613865,"threshold_uncertainty_score":0.9999248,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2082211942","doi":"10.1186/1471-2407-10-255","title":"The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors","year":2010,"lang":"en","type":"article","venue":"BMC Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Cetuximab; Trastuzumab; Monoclonal antibody; Medicine; Immunohistochemistry; Distribution (mathematics); Cancer research; Surgical oncology; Carcinoma; Antibody; Pathology; Internal medicine; Cancer; Immunology; Breast cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03490997489727181,"gpt":0.366115816217177,"spread":0.3312058413199052,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004081021,0.0001134866,0.000198582,0.00001834811,0.0002093451,0.0000263582,0.0001793573,0.0000629526,0.0000701454],"category_scores_gemma":[0.0001410841,0.00005788962,0.00007244198,0.0001617167,0.0006242648,0.00003615865,0.00007228773,0.0004416176,0.00000303406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009933441,"about_ca_system_score_gemma":0.0006963451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004576881,"about_ca_topic_score_gemma":0.001604881,"domain_scores_codex":[0.998836,0.00006059135,0.0002314131,0.0001849011,0.0004262217,0.00026084],"domain_scores_gemma":[0.9991805,0.0001431252,0.00009764946,0.0003700638,0.0001383036,0.00007034454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001198256,0.0002280454,0.8165585,0.0005458822,0.0002547835,0.00000664847,0.002828458,0.00006261614,0.1088147,0.006960758,0.006997924,0.05554338],"study_design_scores_gemma":[0.001177832,0.0001479887,0.9363226,0.0001787077,0.00007571343,0.00005142485,0.0003630767,0.001643348,0.04848713,0.0007726478,0.01065827,0.0001212407],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933549,0.003140327,0.00006002015,0.002066683,0.0004746233,0.0004423712,0.0000747911,0.00001769764,0.0003686365],"genre_scores_gemma":[0.9984049,0.000324074,0.00005723554,0.0001125724,0.0002299351,0.00007658015,0.000004315043,0.00001712564,0.0007732725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1197641,"threshold_uncertainty_score":0.236067,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143386010","doi":"10.1186/1471-2407-10-190","title":"A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma","year":2010,"lang":"en","type":"article","venue":"BMC Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôpital Saint-Luc; University of Alberta","funders":"Universitätsklinikum Regensburg","keywords":"Medicine; Sirolimus; Clinical endpoint; Immunosuppression; Internal medicine; Hepatocellular carcinoma; Transplantation; Randomized controlled trial; Liver transplantation; Everolimus; Discovery and development of mTOR inhibitors; Surgical oncology; Oncology; Temsirolimus; PI3K/AKT/mTOR pathway","retraction":null,"screen_n_in":null,"score":{"opus":0.02593519089566828,"gpt":0.2837044156237285,"spread":0.2577692247280602,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003465425,0.0002652204,0.0003467064,0.00006816683,0.0001637866,0.0000865476,0.0004991136,0.0002420828,0.00002788457],"category_scores_gemma":[0.0002055675,0.0002716548,0.0001339049,0.00009443166,0.00005883731,0.00003253396,0.0001639628,0.0002300778,0.000001611016],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001637319,"about_ca_system_score_gemma":0.0004175047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004438009,"about_ca_topic_score_gemma":0.003229283,"domain_scores_codex":[0.9982824,0.00009240199,0.0004134931,0.000606427,0.0002145534,0.0003907452],"domain_scores_gemma":[0.9989672,0.0001448037,0.0002207941,0.0004295886,0.0001576139,0.00008005353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5392017,0.0002215076,0.2551291,0.0001826501,0.00009216172,0.000004901141,0.0004096151,0.0003279188,0.2035562,0.00004619699,0.0003523892,0.0004756135],"study_design_scores_gemma":[0.6879826,0.002027429,0.019815,0.0001929565,0.0001374488,0.000001980876,0.0000712386,0.002420755,0.2860551,0.00006585853,0.0006268778,0.0006027697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934078,0.0005795539,0.0007947111,0.000009143045,0.001983761,0.002855325,0.00005832945,0.00001736522,0.0002939514],"genre_scores_gemma":[0.9964051,0.00008000151,0.001043694,0.00003297154,0.0007895001,0.001352596,0.0001766068,0.00005855857,0.00006093534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2353141,"threshold_uncertainty_score":0.9999735,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2418561090","doi":"10.1186/s12885-016-2385-z","title":"HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer","year":2016,"lang":"en","type":"article","venue":"BMC Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Trastuzumab; Pertuzumab; Anthracycline; Internal medicine; Oncology; Metastatic breast cancer; Breast cancer; Vinorelbine; Cardiotoxicity; Chemotherapy; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02509831432039076,"gpt":0.3684742946253877,"spread":0.3433759803049969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000632346,0.0006691937,0.002792123,0.0003804949,0.00006562121,0.00001879589,0.0002945768,0.0001724695,0.0008218769],"category_scores_gemma":[0.0002807945,0.0004401036,0.0004483113,0.001021253,0.0008663177,0.0003285785,0.00005367285,0.0003884138,0.000007657238],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002942145,"about_ca_system_score_gemma":0.003697813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005107218,"about_ca_topic_score_gemma":0.003205416,"domain_scores_codex":[0.9945405,0.0005353856,0.001488028,0.0009428047,0.001543071,0.0009502486],"domain_scores_gemma":[0.995945,0.001202826,0.0008942185,0.0007646115,0.0008530853,0.0003402121],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8621294,0.003186422,0.003763879,0.0006748433,0.0007900001,0.00002522116,0.000589327,0.0003809981,0.001370118,0.000005875673,0.0002638555,0.12682],"study_design_scores_gemma":[0.96618,0.005540583,0.01469562,0.00474198,0.0006119825,0.000006532166,0.0001197974,0.0004773036,0.006874633,0.000008982853,0.0002329314,0.0005096605],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987031,0.001478222,0.0006903572,0.0005080602,0.0004254388,0.008360045,0.001070206,0.00005898988,0.0003776391],"genre_scores_gemma":[0.9930308,0.002733756,0.0004414088,0.0001693389,0.0003762707,0.002389338,0.00005759808,0.0001780608,0.0006234335],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1263103,"threshold_uncertainty_score":0.9998051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2592196580","doi":"10.1186/s12885-017-3175-y","title":"Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial","year":2017,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; North York General Hospital","funders":"Medical Research Council; University of Glasgow; University of Dundee","keywords":"Medicine; Lung cancer; Lung cancer screening; Internal medicine; National Lung Screening Trial; Stage (stratigraphy); Cancer; Randomized controlled trial; Surgical oncology; Lung; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.0639721456365767,"gpt":0.4599221757309939,"spread":0.3959500300944171,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003684373,0.0002697759,0.00164123,0.0003104166,0.0003208657,0.00009034654,0.0001761231,0.00009131317,0.00007113547],"category_scores_gemma":[0.001618925,0.0001716844,0.0004215152,0.0002529176,0.00008631773,0.0001166178,0.0000544791,0.0001984042,1.419285e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003543612,"about_ca_system_score_gemma":0.0008388172,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05704836,"about_ca_topic_score_gemma":0.06733261,"domain_scores_codex":[0.9975002,0.0004345025,0.0009943916,0.0003976788,0.000300767,0.0003723925],"domain_scores_gemma":[0.9974557,0.001149086,0.0007602901,0.0004138329,0.0001646191,0.00005648908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8943808,0.000476158,0.04337018,0.0002867072,0.0006086639,0.00006586119,0.002614954,0.000101321,0.05685006,0.000001906729,0.0000123218,0.001231052],"study_design_scores_gemma":[0.9591017,0.0008639942,0.00937158,0.001067941,0.0009284226,0.00006175903,0.0008369579,0.01287391,0.01464142,0.000006181732,0.00003392287,0.0002121664],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6776245,0.0001833816,0.0005639168,0.0001341473,0.0003204856,0.3211026,0.00001229204,0.00001454295,0.00004408005],"genre_scores_gemma":[0.6252918,0.00001333022,0.0004940474,0.00004440549,0.00025362,0.3737568,2.133869e-7,0.00002699178,0.0001188279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06472093,"threshold_uncertainty_score":0.9496862,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2997703943","doi":"10.1186/s12885-019-6442-2","title":"A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Université Laval; BC Children's Hospital; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Calgary; McGill University; University of British Columbia; Hospital for Sick Children; Université de Montréal; Montreal Children's Hospital; Centre hospitalier universitaire de Québec; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Trametinib; Medicine; Neurofibromatosis; MAPK/ERK pathway; Refractory (planetary science); Glioma; Cancer research; Internal medicine; Oncology; Neurofibroma; Pathology; Signal transduction; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02066568916908531,"gpt":0.2824107083923213,"spread":0.261745019223236,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004825327,0.0001477878,0.0003137208,0.00009048835,0.00003405034,0.000006463413,0.00005072056,0.00002827455,0.00004191594],"category_scores_gemma":[0.00003007068,0.00007075926,0.00004455655,0.0002986227,0.00002943636,0.00007124952,0.00001461743,0.00005189346,3.335384e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004891686,"about_ca_system_score_gemma":0.0002021113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001671321,"about_ca_topic_score_gemma":0.0001544866,"domain_scores_codex":[0.999077,0.00002288378,0.0002244556,0.000234002,0.0003031307,0.000138565],"domain_scores_gemma":[0.9991183,0.0001266639,0.0002957426,0.0002676834,0.0001362387,0.00005539889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01185873,0.009010633,0.9724575,0.0004979816,0.0001226558,0.000004755318,0.0007747619,0.00001100013,0.00166775,0.000007487609,0.00007412084,0.003512606],"study_design_scores_gemma":[0.04378331,0.02952424,0.9122123,0.0001720645,0.0004240065,0.000005125647,0.0005679152,0.00003547133,0.01300225,0.000002611226,0.000162711,0.0001080265],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965852,0.00005724158,0.000003918219,0.00002873583,0.00005544049,0.003129837,0.0001049809,0.00000991544,0.0000247321],"genre_scores_gemma":[0.9992908,0.000005320746,0.0002005331,0.00002680992,0.00004303386,0.000363646,0.00001089898,0.0000269826,0.00003193377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06024524,"threshold_uncertainty_score":0.2885479,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108086764","doi":"10.1186/1471-2407-6-34","title":"Understanding the attitudes of the elderly towards enrolment into cancer clinical trials","year":2006,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Referral; Cancer; Family medicine; Geriatric oncology; Surgical oncology; Population; Accrual; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.880292108887154,"gpt":0.6881005721360686,"spread":0.1921915367510855,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01652275,0.000133515,0.0006027477,0.00003655644,0.0001646363,0.00003054471,0.0004250482,0.0003016886,0.0008181678],"category_scores_gemma":[0.01218044,0.00006322959,0.0004836898,0.0002726069,0.0008291744,0.00003104701,0.0002065724,0.001298272,0.00000691131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006060582,"about_ca_system_score_gemma":0.002692419,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.007660138,"about_ca_topic_score_gemma":0.03657511,"domain_scores_codex":[0.9959173,0.0008929672,0.001242762,0.0003334598,0.001320583,0.0002929441],"domain_scores_gemma":[0.9846107,0.01389434,0.0003847372,0.0007085302,0.0003016418,0.00009999273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001045223,0.0004408127,0.9161311,0.0006887047,0.000393982,0.00000353725,0.0003457675,0.0003577338,0.001200913,0.04127897,0.02085872,0.01725448],"study_design_scores_gemma":[0.005718148,0.0007521536,0.8661566,0.002192659,0.0006123054,0.000002879843,0.0006570676,0.0003100573,0.004247665,0.1020049,0.0170646,0.0002809642],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8180462,0.01561182,0.009156482,0.1212005,0.006001563,0.004229484,0.0001012011,0.00009987874,0.02555288],"genre_scores_gemma":[0.9894357,0.00255363,0.0003064882,0.001040821,0.001558319,0.0001605134,0.000001265058,0.00002283672,0.004920384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1713895,"threshold_uncertainty_score":0.9989479,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118228232","doi":"10.1186/s12885-015-1421-8","title":"Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms","year":2015,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Foundation; VGH and UBC Hospital Foundation","keywords":"KRAS; CDKN2A; PTEN; Cancer research; STK11; Biology; Ovarian cancer; Mucinous carcinoma; Massive parallel sequencing; Genetic heterogeneity; Exome sequencing; Cancer; Adenocarcinoma; Mutation; DNA sequencing; Gene; Colorectal cancer; Genetics; PI3K/AKT/mTOR pathway; Phenotype; Signal transduction","retraction":null,"screen_n_in":null,"score":{"opus":0.04550892229067718,"gpt":0.2958274871775814,"spread":0.2503185648869043,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002635058,0.0002192712,0.0005423268,0.0001822716,0.00006495605,0.00001882995,0.00005711666,0.00008880957,0.00005989023],"category_scores_gemma":[0.000485727,0.0002037848,0.00006079133,0.0004494204,0.00005354557,0.0001415097,0.00003921454,0.0001715707,0.000001760439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001444403,"about_ca_system_score_gemma":0.001307199,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02400666,"about_ca_topic_score_gemma":0.02129414,"domain_scores_codex":[0.9984052,0.00006314433,0.0005067429,0.0004016673,0.0002777409,0.0003455456],"domain_scores_gemma":[0.9988097,0.0002204905,0.0002652149,0.0002511454,0.0002389349,0.0002145181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004524984,0.0002557463,0.9376005,0.0004361126,0.0001776947,0.0001161868,0.008530105,0.01359425,0.01512277,0.0001471135,0.0001789524,0.0233881],"study_design_scores_gemma":[0.02463049,0.0008572327,0.8911837,0.003414812,0.0002884173,0.0001602327,0.008706397,0.03555442,0.03257912,0.0004081592,0.001397219,0.0008197529],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936888,0.003573514,0.0006631233,0.0004743254,0.0002303043,0.0007460623,0.0000658397,0.00004589846,0.0005121052],"genre_scores_gemma":[0.9898577,0.0001263873,0.009062861,0.0002546955,0.0001941495,0.0002926681,0.00003954332,0.0000388345,0.0001331281],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04641672,"threshold_uncertainty_score":0.9965647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007987084","doi":"10.1186/1471-2407-11-437","title":"A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence","year":2011,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; University of Toronto; Ontario Institute for Cancer Research; Helsingin ja Uudenmaan Sairaanhoitopiiri; Helsingin Yliopisto","keywords":"Medicine; Proportional hazards model; Cohort; Microarray; Gene signature; Surgical oncology; Microarray analysis techniques; Oncology; Cancer; Pathology; Carcinoma; Internal medicine; Gene expression; Gene; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1098071965972706,"gpt":0.3670278737913708,"spread":0.2572206771941002,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002055807,0.0004528003,0.00295883,0.000204824,0.00003401714,0.000003396662,0.0002260542,0.000564219,0.0009534855],"category_scores_gemma":[0.0000612154,0.0003139371,0.0005224588,0.0004804388,0.0002218137,0.00004082626,0.0001409699,0.0008232773,0.00001422603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005607586,"about_ca_system_score_gemma":0.001786498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008056154,"about_ca_topic_score_gemma":0.0006767106,"domain_scores_codex":[0.9977722,0.0001415412,0.0007425515,0.0006075007,0.0002944328,0.0004417338],"domain_scores_gemma":[0.998863,0.0001155898,0.0003366754,0.0003604463,0.0001667412,0.0001575527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000952896,0.0003805747,0.0174613,0.02808722,0.0003514352,0.0004352264,0.00107769,4.134495e-7,0.000001518064,0.00007070689,0.01338788,0.9377931],"study_design_scores_gemma":[0.001055936,0.0005188049,0.006499763,0.01226952,0.0007417568,0.00009691466,0.00001535205,0.000003586327,0.000009202193,0.00000568456,0.978474,0.0003095441],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006940035,0.992058,0.000005881755,0.00003653876,0.0004622141,0.0009528627,0.0004826642,0.00002373904,0.005284047],"genre_scores_gemma":[0.001352204,0.9963472,0.0002811923,0.00007757075,0.0002643835,0.0004988983,0.00004664023,0.00003636972,0.001095506],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.965086,"threshold_uncertainty_score":0.9999598,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2939094855","doi":"10.1186/s12885-019-5403-0","title":"Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":147,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"William Osler Health System","funders":"Fundação para a Ciência e a Tecnologia; Centro de Investigação em Biomedicina","keywords":"DNA methylation; Breast cancer; CpG site; Methylation; Epigenetics; Biology; Cancer; Gene; Promoter; Cancer research; Gene expression; Surgical oncology; Regulation of gene expression; Epigenomics; Genetics; Medicine; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.01524821200169203,"gpt":0.2858156464134292,"spread":0.2705674344117372,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001792933,0.0001055612,0.0001347336,0.00007343529,0.00001541659,0.0000116545,0.00009411194,0.0001083107,0.0001166815],"category_scores_gemma":[0.00002808309,0.0001028961,0.00006088679,0.0001558274,0.00003437663,0.000006238677,0.00004461119,0.00003913644,0.000004254714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003191032,"about_ca_system_score_gemma":0.0001508867,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008214159,"about_ca_topic_score_gemma":0.00180718,"domain_scores_codex":[0.9991853,0.00003332124,0.0002340337,0.0002617119,0.0001324253,0.0001532394],"domain_scores_gemma":[0.9995149,0.00001782685,0.0001321406,0.0001980339,0.0001046175,0.00003241463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00005520067,0.00002600625,0.3626699,0.00004748244,0.00002330667,5.593327e-8,0.00002685847,0.0011189,0.6342667,0.00001129957,0.00004117782,0.001713058],"study_design_scores_gemma":[0.0005084353,0.00002694066,0.5834339,0.00005450391,0.0000157723,3.508274e-7,0.00003265672,0.0003799049,0.4145755,0.00003771339,0.0008176856,0.0001166858],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933875,0.004723955,0.0007700995,0.00008221865,0.0003497663,0.0002821024,0.00008476183,0.000004554596,0.0003150284],"genre_scores_gemma":[0.9983713,0.0006577169,0.0002720293,0.00002369968,0.0001052307,0.00006556456,0.00004773597,0.00001711155,0.0004396072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.220764,"threshold_uncertainty_score":0.419598,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2169948124","doi":"10.1186/1471-2407-11-417","title":"Cyclin D1, Id1 and EMT in breast cancer","year":2011,"lang":"en","type":"article","venue":"BMC Cancer","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":145,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Genetics; Malmö Högskola; Lunds Universitet; Knut och Alice Wallenbergs Stiftelse; Vetenskapsrådet; Karolinska Institutet; Cancerfonden","keywords":"Cyclin D1; Gene silencing; Cancer research; Cell cycle; Cyclin D; Breast cancer; Cyclin B; Biology; Cyclin; Cancer; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02372724340402902,"gpt":0.278964475680731,"spread":0.255237232276702,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004953088,0.000103669,0.00009362129,0.00002653787,0.00002572581,0.000008628867,0.0001002865,0.0000818511,0.0003360116],"category_scores_gemma":[0.00001110162,0.00009907241,0.0000322924,0.00004884992,0.00006182509,0.000002933187,0.0000651525,0.000045918,0.000005491305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001994453,"about_ca_system_score_gemma":0.0001585582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001283004,"about_ca_topic_score_gemma":0.003749499,"domain_scores_codex":[0.9993544,0.00002355556,0.0001211507,0.0002621914,0.00006140632,0.000177312],"domain_scores_gemma":[0.9996783,0.000004607129,0.00004108164,0.000174326,0.00002983038,0.00007190996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002612326,0.0000795119,0.8789482,0.00005582895,0.00003072702,0.000003897839,0.0001763573,0.00005906777,0.1122155,0.00001687535,0.003486542,0.004666234],"study_design_scores_gemma":[0.0007288799,0.0000271003,0.9057792,0.00007180967,0.00002316074,0.00000660054,0.00005228827,0.00003406166,0.08324657,0.00005318104,0.009721939,0.0002552219],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926966,0.006334912,0.00005211008,0.00004292795,0.0001889306,0.00008866188,0.00008414133,0.00001031814,0.0005014091],"genre_scores_gemma":[0.9980378,0.0004879651,0.0002448899,0.0002680537,0.0002555317,0.0001042436,0.00001066179,0.00001913515,0.0005717534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02896897,"threshold_uncertainty_score":0.4040056,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089600839","doi":"10.1186/1471-2407-13-133","title":"Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) – study protocol for a randomized phase II trial","year":2013,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital; London Health Sciences Centre; Western University","funders":"Canadian Cancer Society Research Institute; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Medicine; Transoral robotic surgery; Oncology; Radiation therapy; Surgical oncology; Randomized controlled trial; Internal medicine; Clinical endpoint; Chemotherapy; Stage (stratigraphy); Quality of life (healthcare); Population; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.05657445934050642,"gpt":0.3626983021412415,"spread":0.3061238428007351,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006766054,0.0003087347,0.001758439,0.00009093343,0.0002028138,0.00002147766,0.0001534431,0.00008681911,0.0007842675],"category_scores_gemma":[0.00009959133,0.00018135,0.0006791561,0.0002623799,0.0001831301,0.00009652523,0.00002807686,0.0001582683,0.000001883354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001454596,"about_ca_system_score_gemma":0.0008811692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0027411,"about_ca_topic_score_gemma":0.0003773417,"domain_scores_codex":[0.9976946,0.0003322618,0.0007809213,0.0003765169,0.0004015461,0.00041415],"domain_scores_gemma":[0.9983552,0.0005447765,0.000298463,0.0004464835,0.0002221147,0.0001329954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9555599,0.00457001,0.01793317,0.001035521,0.0002321491,0.000005738096,0.004067255,0.00003741261,0.002379699,0.000004582326,0.01223603,0.001938548],"study_design_scores_gemma":[0.9792406,0.005327056,0.006127202,0.00009712074,0.000358108,9.912783e-7,0.0001898521,0.0004829571,0.003053445,0.000005469503,0.00487427,0.0002429145],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6796257,0.0003188686,0.0002254217,0.0003201378,0.0004493121,0.3189241,0.00002355389,0.0000300167,0.00008288659],"genre_scores_gemma":[0.587279,0.000006983504,0.00009749002,0.0001760924,0.0003529176,0.4105126,0.000001144616,0.00003834667,0.001535399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09234669,"threshold_uncertainty_score":0.8587179,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2895349961","doi":"10.1186/s12885-018-4868-6","title":"Patients’ quality of life during active cancer treatment: a qualitative study","year":2018,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"Fondation de France","keywords":"Quality of life (healthcare); Medicine; Qualitative research; Thematic analysis; Cancer treatment; Surgical oncology; Disease; Qualitative property; Perception; Family medicine; Cancer; Oncology; Psychology; Internal medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.09675934133710799,"gpt":0.4332101057411497,"spread":0.3364507644040417,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001509945,0.0002036489,0.0005466002,0.00008608327,0.00008711374,0.000007527749,0.00007523117,0.00006219617,0.001135147],"category_scores_gemma":[0.00009621014,0.0001631715,0.0001527898,0.0003008849,0.0001498427,0.0000848225,0.00003869342,0.00008419238,0.00001337908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006728906,"about_ca_system_score_gemma":0.0005666363,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06854705,"about_ca_topic_score_gemma":0.178934,"domain_scores_codex":[0.9983259,0.0002459264,0.0003949688,0.0003743944,0.0004043278,0.0002544498],"domain_scores_gemma":[0.9986123,0.0001074712,0.0002482821,0.0003451308,0.0005213182,0.0001654754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00462306,0.001011609,0.7384458,0.0001984262,0.0004837126,9.175e-7,0.2502042,0.000001859086,0.0004874752,0.0000241344,0.0001347797,0.004384088],"study_design_scores_gemma":[0.006907955,0.001351481,0.9099756,0.0001247052,0.0002006226,1.480351e-7,0.07395561,0.000002972319,0.006288584,0.00001432074,0.0009751842,0.0002028047],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958077,0.0006337914,0.00001070465,0.00008228799,0.0005952377,0.0008585296,0.0003529775,0.00004035403,0.001618407],"genre_scores_gemma":[0.9969771,0.00009063076,0.00001611393,0.0001281961,0.0005660754,0.0005507858,0.00001236265,0.0000288881,0.001629842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1762486,"threshold_uncertainty_score":0.999778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2080073306","doi":"10.1186/1471-2407-10-202","title":"Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy","year":2010,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children; University Health Network; Queen's University","funders":"National Cancer Institute; Hospital for Sick Children; Terry Fox Foundation","keywords":"Osteosarcoma; Carcinogenesis; RUNX2; Cancer research; Chemotherapy; Medicine; Surgical oncology; Biomarker; Pathology; Gene; Gene expression; Biology; Oncology; Cancer; Internal medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.0173297875356536,"gpt":0.3003121343397703,"spread":0.2829823468041167,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001790685,0.0001633633,0.0004952775,0.0002895489,0.00005496894,0.000006831605,0.00006724383,0.00008543643,0.0004738764],"category_scores_gemma":[0.00005192146,0.0001022431,0.0001134044,0.000602681,0.00005768674,0.0000499904,0.00001902457,0.00009255809,7.84411e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008811634,"about_ca_system_score_gemma":0.0001336345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005047024,"about_ca_topic_score_gemma":0.002245046,"domain_scores_codex":[0.9988269,0.00006987384,0.0002729149,0.0002627788,0.0004115607,0.0001559587],"domain_scores_gemma":[0.998857,0.0001777544,0.000301339,0.0003512256,0.0002049581,0.0001077618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003496726,0.0003323813,0.5631054,0.00001239226,0.0002913078,0.000003978384,0.0002599442,0.0002605186,0.4313359,0.000004950254,0.0001073799,0.0007891043],"study_design_scores_gemma":[0.002388559,0.0005046599,0.6816149,0.0005131578,0.0005828349,0.00000139652,0.00007602914,0.0002231391,0.3139282,0.000001572399,0.00007996835,0.00008559811],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989186,0.0001714341,0.00008342021,0.0001276565,0.00002501266,0.0004938066,0.00006393476,0.00002358324,0.00009258618],"genre_scores_gemma":[0.9980981,0.000007774197,0.001232571,0.00009878995,0.00003199074,0.0001309176,0.00005650122,0.00002747509,0.0003158702],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1185095,"threshold_uncertainty_score":0.5188614,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2794460351","doi":"10.1186/s12885-018-4242-8","title":"Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers","year":2018,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Université de Montréal; Ottawa Hospital; University of Manitoba; University of Calgary; Vancouver General Hospital; University of British Columbia; Jewish General Hospital; Ontario Institute for Cancer Research; Université de Sherbrooke; University of Toronto; Centre hospitalier universitaire de Québec; BC Cancer Agency; University of Ottawa; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Terry Fox Research Institute","keywords":"Surgical oncology; Medicine; Ovarian cancer; Cohort; Oncology; Outcome (game theory); Internal medicine; Gynecology; Cohort study; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.04242073023013328,"gpt":0.3299152084129289,"spread":0.2874944781827957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001219117,0.0001077061,0.0002223276,0.00005320368,0.0001035905,0.0000145851,0.00005425076,0.00006051966,0.000362676],"category_scores_gemma":[0.00004980724,0.00007440405,0.0000658169,0.0001217121,0.0001117322,0.00002972949,0.00001499748,0.00003718584,0.000002267139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003522311,"about_ca_system_score_gemma":0.0006260643,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1162521,"about_ca_topic_score_gemma":0.1638558,"domain_scores_codex":[0.9992588,0.00001616735,0.0002137985,0.0002018453,0.000121223,0.000188152],"domain_scores_gemma":[0.9993004,0.00003909547,0.0001160991,0.0002334391,0.0001738404,0.0001371507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008437446,0.00002213894,0.9898318,0.00009491514,0.0001794571,5.767535e-7,0.00008942832,4.041137e-7,0.000122258,0.000193377,0.003375013,0.006006239],"study_design_scores_gemma":[0.001145857,0.00007272194,0.9592357,0.0001254904,0.0004146827,0.000002662164,0.00001383025,0.0001081704,0.002501249,0.00001824507,0.03628262,0.00007879873],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891021,0.0005048569,0.0001048842,0.005599132,0.001388784,0.001425186,0.0009769758,0.0000135825,0.0008845257],"genre_scores_gemma":[0.9969227,0.0002254766,0.0003431115,0.0008633996,0.0004354624,0.0004052564,0.0000238216,0.0000199572,0.0007607794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04760374,"threshold_uncertainty_score":0.8896329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1841467563","doi":"10.1186/s12885-015-1664-4","title":"Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis","year":2015,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Health and Medical Research Council; Medical Research Council; National Breast Cancer Foundation","keywords":"Medicine; Meta-analysis; Breast cancer; Magnetic resonance imaging; Mammography; Radiology; Surgical oncology; Breast MRI; Neoadjuvant therapy; Receiver operating characteristic; Breast imaging; Ultrasound; Nuclear medicine; Cancer; Pathology; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1468706360107949,"gpt":0.3800319930458704,"spread":0.2331613570350755,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002408249,0.0006947009,0.002709671,0.00008328824,0.00007043411,0.00006956408,0.0003706603,0.000150586,0.00007541411],"category_scores_gemma":[0.00001538528,0.0004223243,0.0003376761,0.0002153295,0.0002351353,0.00001013594,0.0008727301,0.0001590164,0.000002286396],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000838128,"about_ca_system_score_gemma":0.0002441749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004345634,"about_ca_topic_score_gemma":0.001650165,"domain_scores_codex":[0.9973248,0.0002102384,0.0005020823,0.00126399,0.0003722562,0.0003266592],"domain_scores_gemma":[0.9981012,0.00007718354,0.0005942199,0.0009462876,0.0001286892,0.0001524253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003104428,0.0003027943,0.06078947,0.001900695,0.3551353,0.00005786091,0.0005601491,0.00001783404,8.231445e-7,0.000001303088,0.002859252,0.5780641],"study_design_scores_gemma":[0.001273513,0.0004663645,0.01760709,0.0003614232,0.4325763,0.0001047077,0.0001538404,0.00000404395,0.00000923122,0.000007434542,0.5464274,0.001008642],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001451496,0.9845619,0.00008092121,0.00008482052,0.00003760004,0.0008038288,0.01293946,0.000009699954,0.0000303187],"genre_scores_gemma":[0.01006064,0.984167,0.001855672,0.0002022044,0.0003164987,0.001146003,0.002107884,0.00006362458,0.00008044577],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5770555,"threshold_uncertainty_score":0.9998229,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2535056227","doi":"10.1186/s12885-016-2835-7","title":"Phase-specific and lifetime costs of cancer care in Ontario, Canada","year":2016,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":130,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"BC Cancer Agency; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; University Health Network; Toronto General Hospital; Toronto Public Health; Centre for Addiction and Mental Health","funders":"Canadian Cancer Society Research Institute; Simon Fraser University; University of Toronto; Ontario Ministry of Health and Long-Term Care; Canadian Centre for Applied Research in Cancer Control; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Surgical oncology; Medicine; Phase (matter); Cancer; Gerontology; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02683046087616615,"gpt":0.2388261748388893,"spread":0.2119957139627231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001044066,0.0001612552,0.0004683533,0.0001149979,0.00003414372,0.00001634378,0.0001509249,0.00008605677,0.002543689],"category_scores_gemma":[0.00002203634,0.0001530057,0.00005041228,0.00009651906,0.00008027323,0.0001951192,0.00004023812,0.00009474258,0.0000136979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002729335,"about_ca_system_score_gemma":0.001042051,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9842466,"about_ca_topic_score_gemma":0.9991208,"domain_scores_codex":[0.998725,0.000006386401,0.0005390616,0.0003712825,0.00003576332,0.0003225006],"domain_scores_gemma":[0.9992782,0.00004856617,0.000290951,0.0002261276,0.00004515409,0.0001109524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001597424,0.00004179265,0.9477811,0.00003167054,0.00002567373,0.000002317845,0.0005037015,0.00003604761,0.00008417104,0.01085395,0.005981755,0.0344981],"study_design_scores_gemma":[0.004139346,0.00009412612,0.500761,0.0002058908,0.000005613873,6.384662e-7,0.00009078138,0.0000181112,0.0005388219,0.0007240857,0.4930467,0.0003749467],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9478472,0.03983048,0.00009082378,0.0003566744,0.0007550612,0.0002086285,0.0009119902,0.000007761966,0.009991317],"genre_scores_gemma":[0.993792,0.003484516,0.00007356937,0.0002203343,0.0001335331,0.0000821898,0.000003737531,0.00002359446,0.00218652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4870649,"threshold_uncertainty_score":0.9983681,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1551518644","doi":"10.1186/1471-2407-6-237","title":"Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma","year":2006,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Osteosarcoma; Surgical oncology; Medicine; Cancer research; Metastasis; Survival analysis; Pathological; Gene; Oncology; Internal medicine; Biology; Cancer; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01323765789531102,"gpt":0.2551868485382457,"spread":0.2419491906429347,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030482,0.0000746342,0.0001920162,0.00002830582,0.00001862892,0.000002497044,0.00001161962,0.00003871006,0.000006287347],"category_scores_gemma":[0.00001217049,0.00004400307,0.00001030832,0.00004930811,0.0000796637,0.00001767594,0.00003402161,0.00005246115,4.813052e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001455817,"about_ca_system_score_gemma":0.000009146274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004811121,"about_ca_topic_score_gemma":0.0002563804,"domain_scores_codex":[0.999553,0.00002101817,0.00008987323,0.0001363312,0.0001106894,0.00008907785],"domain_scores_gemma":[0.9998195,0.00004839613,0.00003310014,0.00005312361,0.00002085372,0.0000250951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007808727,0.0002068083,0.992021,0.00008046348,0.000003062403,0.000007561608,0.00002289535,2.034716e-7,0.004689948,0.00001344546,0.00005533041,0.002118385],"study_design_scores_gemma":[0.003473867,0.0007330138,0.9792883,0.0002770308,0.00001663316,6.950496e-7,0.00001912314,5.533922e-7,0.01608404,0.00001277652,0.00004087387,0.00005306917],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997849,0.001379822,0.000003073284,0.00001394608,0.00003410567,0.0004592482,0.000005331447,0.000007085014,0.000248349],"genre_scores_gemma":[0.9996108,0.00006163855,0.0001470369,0.00002687797,0.00003013581,0.0000656102,0.000003753812,0.000005198317,0.00004896097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0127327,"threshold_uncertainty_score":0.1794393,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079418758","doi":"10.1186/1471-2407-14-471","title":"Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis","year":2014,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; BC Cancer Agency; University of Ottawa","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Medicine; Gemcitabine; Internal medicine; Oncology; Pancreatic cancer; Randomized controlled trial; Meta-analysis; Febrile neutropenia; Oxaliplatin; Cochrane Library; Capecitabine; Neutropenia; Chemotherapy; Cancer; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.171461856701966,"gpt":0.472486086826139,"spread":0.301024230124173,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001785192,0.0007263452,0.02513517,0.0002286867,0.000137736,0.00002734912,0.0002689956,0.00036697,0.001148787],"category_scores_gemma":[0.0004449507,0.0004354516,0.00388599,0.001037004,0.0001387006,0.00003691777,0.00005428784,0.0003543228,0.00001893669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004226882,"about_ca_system_score_gemma":0.001278848,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002001423,"about_ca_topic_score_gemma":0.000421334,"domain_scores_codex":[0.9958323,0.0006388618,0.001559662,0.0008661714,0.0004225646,0.0006803912],"domain_scores_gemma":[0.9951472,0.001815736,0.001232179,0.001193434,0.0002949577,0.0003165158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00003090145,0.00002343897,0.00005257294,0.7903015,0.1991456,0.000002011519,0.00001282542,0.00000220911,2.088086e-8,0.00004401774,0.005186387,0.005198503],"study_design_scores_gemma":[0.0004399121,0.00009088875,0.000003346186,0.1266718,0.6040204,0.0000178741,0.000002695615,0.00006258195,2.916995e-8,0.00001474887,0.268432,0.000243782],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[7.002953e-7,0.98455,0.0009888195,0.0004938252,0.0000692497,0.01334748,0.0002012531,0.00004951137,0.0002991616],"genre_scores_gemma":[6.257183e-7,0.940515,0.002749467,0.001862303,0.0003522382,0.03547513,0.0001256689,0.0001077341,0.01881177],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6636297,"threshold_uncertainty_score":0.9998097,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2807132016","doi":"10.1186/s12885-018-4302-0","title":"In silico cancer research towards 3R","year":2018,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pontifical Institute of Mediaeval Studies; University of Toronto; University Health Network","funders":"TU Graz, Internationale Beziehungen und Mobilitätsprogramme","keywords":"In silico; Computer science; Computational model; Computational biology; Data science; Biochemical engineering; Bioinformatics; Biology; Artificial intelligence","retraction":null,"screen_n_in":null,"score":{"opus":0.1242220082073206,"gpt":0.4999837405503089,"spread":0.3757617323429883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007742589,0.0003275138,0.0008397812,0.00029847,0.00005348159,0.00004663269,0.0006386897,0.0005540154,0.0006506172],"category_scores_gemma":[0.0001342818,0.0002820496,0.0004310497,0.0006128742,0.0002035618,0.000004084367,0.000434838,0.0004060873,0.00006198083],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002997228,"about_ca_system_score_gemma":0.001701799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003602935,"about_ca_topic_score_gemma":0.01238944,"domain_scores_codex":[0.9975665,0.0003310326,0.0004498004,0.0008436124,0.0003143728,0.000494683],"domain_scores_gemma":[0.9985583,0.00002396975,0.0001552608,0.000920792,0.000256483,0.00008515542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002064674,0.00006531924,0.00007386191,0.005037382,0.0001920964,0.00001028523,0.00002107207,5.939211e-7,0.001469349,0.000005258661,0.3248711,0.668233],"study_design_scores_gemma":[0.00008512005,0.00004447268,0.000006653838,0.002172195,0.00013556,0.000003281888,0.000004161234,0.000001382266,0.006543523,0.00001511037,0.9906774,0.0003110987],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001034051,0.9960191,0.00003781265,0.00002384498,0.0001021154,0.0005401117,0.0000412451,0.00001580935,0.003116552],"genre_scores_gemma":[0.00002568221,0.9815726,0.0001870196,0.0001030617,0.001722814,0.001585588,0.0001146275,0.00008010617,0.01460852],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.667922,"threshold_uncertainty_score":0.9999632,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}